MTD vs. NVO

Last updated Apr 2, 2026

Compare and contrast key facts about Mettler-Toledo International Inc. (MTD) and Novo Nordisk A/S (NVO).

Performance

MTD vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Mettler-Toledo International Inc. (MTD) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

MTD vs. NVO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
MTD Mettler-Toledo International Inc.	-8.62%	13.93%	0.88%	-16.08%	-14.83%	48.92%	43.67%	40.26%	-8.71%	48.01%
NVO Novo Nordisk A/S	-25.80%	-39.22%	-15.93%	54.84%	22.66%	63.52%	23.33%	28.70%	-12.98%	52.92%

Fundamentals

Market Cap MTD : $25.97B NVO : $162.26B
EPS MTD : $42.24 NVO : $22.15
PE Ratio MTD : 30.16 NVO : 1.65
PEG Ratio MTD : 4.63 NVO : 0.07
PS Ratio MTD : 6.51 NVO : 0.55
Total Revenue (TTM) MTD : $4.03B NVO : $297.20B
Gross Profit (TTM) MTD : $2.32B NVO : $240.66B
EBITDA (TTM) MTD : $1.24B NVO : $153.18B

Returns By Period

In the year-to-date period, MTD achieves a -8.62% return, which is significantly higher than NVO's -25.80% return. Over the past 10 years, MTD has outperformed NVO with an annualized return of 13.80%, while NVO has yielded a comparatively lower 5.04% annualized return.

MTD

• 1D: 1.02%
• 1M: -3.85%
• YTD: -8.62%
• 6M: -1.22%
• 1Y: 10.18%
• 3Y*: -5.92%
• 5Y*: 1.63%
• 10Y*: 13.80%

NVO

• 1D: -0.73%
• 1M: -0.01%
• YTD: -25.80%
• 6M: -36.19%
• 1Y: -43.88%
• 3Y*: -20.88%
• 5Y*: 3.69%
• 10Y*: 5.04%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

MTD vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MTD

MTD Risk / Return Rank: 49
MTD Sharpe Ratio Rank: 51
MTD Sortino Ratio Rank: 46
MTD Omega Ratio Rank: 44
MTD Calmar Ratio Rank: 50
MTD Martin Ratio Rank: 52

NVO

NVO Risk / Return Rank: 10
NVO Sharpe Ratio Rank: 8
NVO Sortino Ratio Rank: 11
NVO Omega Ratio Rank: 10
NVO Calmar Ratio Rank: 11
NVO Martin Ratio Rank: 11

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MTD vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Mettler-Toledo International Inc. (MTD) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	MTD	NVO	Difference
Sharpe ratio Return per unit of total volatility	0.30	-0.81	+1.11
Sortino ratio Return per unit of downside risk	0.67	-0.99	+1.66
Omega ratio Gain probability vs. loss probability	1.08	0.86	+0.22
Calmar ratio Return relative to maximum drawdown	0.35	-0.82	+1.17
Martin ratio Return relative to average drawdown	1.03	-1.41	+2.45
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

MTD vs. NVO - Sharpe Ratio Comparison

The current MTD Sharpe Ratio is 0.30, which is higher than the NVO Sharpe Ratio of -0.81. The chart below compares the historical Sharpe Ratios of MTD and NVO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	MTD	NVO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.30	-0.81	+1.11
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.05	0.10	-0.05
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.47	0.16	+0.32
Sharpe Ratio (All Time) Calculated using the full available price history	0.54	0.46	+0.08

Correlation

The correlation between MTD and NVO is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

MTD vs. NVO - Dividend Comparison

MTD has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 4.94%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
MTD Mettler-Toledo International Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NVO Novo Nordisk A/S	4.94%	3.31%	1.68%	1.00%	1.20%	1.35%	1.87%	2.14%	1.45%	1.52%	2.87%	0.92%

Drawdowns

MTD vs. NVO - Drawdown Comparison

The maximum MTD drawdown since its inception was -61.43%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for MTD and NVO.

Drawdown Indicators

	MTD	NVO	Difference
Max Drawdown Largest peak-to-trough decline	-61.43%	-74.70%	+13.27%
Max Drawdown (1Y) Largest decline over 1 year	-22.44%	-55.03%	+32.59%
Max Drawdown (5Y) Largest decline over 5 years	-43.47%	-74.70%	+31.23%
Max Drawdown (10Y) Largest decline over 10 years	-43.47%	-74.70%	+31.23%
Current Drawdown Current decline from peak	-25.17%	-73.49%	+48.32%
Average Drawdown Average peak-to-trough decline	-13.58%	-17.56%	+3.98%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.62%	31.83%	-24.21%

Volatility

MTD vs. NVO - Volatility Comparison

Mettler-Toledo International Inc. (MTD) has a higher volatility of 10.11% compared to Novo Nordisk A/S (NVO) at 9.39%. This indicates that MTD's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	MTD	NVO	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.11%	9.39%	+0.72%
Volatility (6M) Calculated over the trailing 6-month period	19.01%	38.79%	-19.78%
Volatility (1Y) Calculated over the trailing 1-year period	34.01%	54.16%	-20.15%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	31.02%	37.82%	-6.80%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	29.13%	32.28%	-3.15%

Financials

MTD vs. NVO - Profitability Comparison

The chart below illustrates the profitability comparison between Mettler-Toledo International Inc. and Novo Nordisk A/S over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

MTD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Mettler-Toledo International Inc. reported a gross profit of 635.74M and revenue of 1.13B. Therefore, the gross margin over that period was 56.3%.

NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Novo Nordisk A/S reported a gross profit of 54.38B and revenue of 67.28B. Therefore, the gross margin over that period was 80.8%.

MTD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Mettler-Toledo International Inc. reported an operating income of 343.34M and revenue of 1.13B, resulting in an operating margin of 30.4%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Novo Nordisk A/S reported an operating income of 27.12B and revenue of 67.28B, resulting in an operating margin of 40.3%.

MTD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Mettler-Toledo International Inc. reported a net income of 285.77M and revenue of 1.13B, resulting in a net margin of 25.3%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Novo Nordisk A/S reported a net income of 22.96B and revenue of 67.28B, resulting in a net margin of 34.1%.